Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 25-29

  Tretjakovs, Peteris ^a,b   Jurka, Antra ^a   Bormane, Inga ^a   Mikelsone, Indra ^a   Elksne, Karlina ^b   Krievina, Gita ^a   Reihmane, Dace ^a   Verbovenko, Jurijs ^b,c   Bahs, Guntis ^b,c  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Coronary artery disease; Cytokine; Insulin resistance; Unstable angina

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 BLOOD LEVEL; FEMALE; GELATINASE B BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE 1 BLOOD LEVEL; MALE; MYELOPEROXIDASE BLOOD LEVEL; PLASMINOGEN ACTIVATOR INHIBITOR 1 BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VASCULAR CELL ADHESION MOLECULE 1 BLOOD LEVEL;

AGED; ANGINA PECTORIS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANGINA;

EID: 82955189882     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.10.009     Document Type: Article

References (20)

1. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., Kaski J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004, 110:1747-1753.
2. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
3. Miwa K., Igawa A., Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997, 36:37-44.
4. Konstantino Y., Nguyen T.T., Wolk R., Aiello R.J., Terra S.G., Fryburg D.A. Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 2009, 14(2):118-129.
5. Vaughan D.E. PAI-1 and atherothrombosis. J Thromb Haemost 2005, 3(8):1879-1883.
6. Roman R.M., Camargo P.V., Borges F.K., Rossini A.P., Polanczyk C.A. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Coron Artery Dis 2010, 21(3):129-136.
7. Cersosimo E., DeFronzo R.A. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006, 22(6):423-436.
8. Braunwald E. Unstable angina: a classification. Circulation 1989, 80:410-414.
9. Bonora E., Targher G., Alberiche M., Bonadonna R.C. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23(1):57-63.
10. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1995, 28(7):412-419.
11. Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002, 105:2019-2023.
12. Mizia-Stec K., Zahorska-Markiewicz B., Mandecki T., Janowska J., Szulc A., Jastrzebska-Maj E. Serum levels of selected adhesion molecules in patients with coronary artery disease. Int J Cardiol 2002, 83(2):143-150.
13. Eschen O., Christensen J.H., Toft E., Schmidt E.B. Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography. Atherosclerosis 2005, 180(2):327-331.
14. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
15. Mulvihill N., Foley J., Murphy R., Crean P., Walsh M. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 2000, 36:1210-1216.
16. Alexander C.M., Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989, 1:974-982.
17. Juhan-Vague I., Alessi M.C., Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991, 34:457-462.
18. Rudolph V., Goldmann B.U., Bös C., et al. Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction. Int J Cardiol Sep 14 2010, [Epub ahead of print].
19. Heslop C.L., Frohlich J.J., Hill J.S. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010, 55(11):1102-1109.
20. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.